Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (404)	2/19/2000 10:30:00 PM
From: Eric Fader	Respond to of 743

Currently at .55/.57, on a minor pullback after a big run: La Jolla Diagnostics Announces Ongoing Discussions Regarding DiagnosTech Subsidiary LA JOLLA, Calif., Feb 18, 2000 (BW HealthWire) -- La Jolla Diagnostics Inc., (OTCBB:LAJD) announced today that it has entered ongoing discussions regarding its subsidiary, DiagnosTech Inc. Several companies have indicated an interest in the DiagnosTech, Inc. line of rapid diagnostic tests, especially the company's rapid test for active tuberculosis. Under discussion is the possibility of a strategic joint venture, license, merger or outright acquisition of DiagnosTech Inc. The company cannot say what, if any, actions will be forthcoming as a result of these discussions. La Jolla Diagnostics is an emerging company engaged in the development and marketing of health care products, dietary supplements, and through its subsidiary DiagnosTech Inc., state-of-the-art rapid diagnostic tests including a unique proprietary test for active tuberculosis. Copyright (C) 2000 Business Wire. All rights reserved. Distributed via COMTEX. -0- CONTACT: La Jolla Diagnostics Inc. Don Brucker, 800/454-6790, Fax 619/454-7851 lajd.com lajd96@aol.com WEB PAGE: businesswire.com GEOGRAPHY: CALIFORNIA INDUSTRY CODE: MEDICAL BIOTECHNOLOGY PHARMACEUTICAL MEDICAL DEVICES